In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex

As meropenem-clavulanic acid is recommended for the treatment of drug-resistant tuberculosis, the repurposing of new carbapenem combinations may provide new treatment options, including oral alternatives. Therefore, we studied the in vitro activities of meropenem-vaborbactam, meropenem-clavulanic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Economou Lundeberg, Elin, Andersson, Viktoria, Wijkander, Maria, Groenheit, Ramona, Mansjö, Mikael, Werngren, Jim, Cortes, Teresa, Barilar, Ivan, Niemann, Stefan, Merker, Matthias, Köser, Claudio U., Davies Forsman, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580993/
https://www.ncbi.nlm.nih.gov/pubmed/37737628
http://dx.doi.org/10.1128/spectrum.01781-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580993/
https://www.ncbi.nlm.nih.gov/pubmed/37737628
http://dx.doi.org/10.1128/spectrum.01781-23

Ejemplares similares